Bionime Corporation (TPE:4737)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Biotech Department	1.93B	1.76B	2.21B	1.85B	1.67B
Biotech Department Growth	10.15%	-20.58%	19.50%	10.87%	-23.21%
Total	1.93B	1.76B	2.21B	1.85B	1.67B
Total Growth	10.15%	-20.58%	19.50%	10.87%	-23.21%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Algeria	550.95M	340.85M	728.55M	141.81M	251.47M
Algeria Growth	61.64%	-53.22%	413.75%	-43.61%	-41.32%
China	230.94M	251.85M	299.29M	329.83M	173.63M
China Growth	-8.30%	-15.85%	-9.26%	89.97%	-54.55%
United States	170.98M	204.38M	177.30M	190.93M	177.64M
United States Growth	-16.34%	15.27%	-7.14%	7.48%	23.74%
Republic of Belarus	105.50M	68.62M	-	-	-
Republic of Belarus Growth	53.76%	-	-	-	-
United Arab Emirates	38.07M	88.88M	26.98M	-	-
United Arab Emirates Growth	-57.17%	229.40%	-	-	-
Switzerland	57.28M	101.64M	136.45M	234.48M	235.50M
Switzerland Growth	-43.64%	-25.51%	-41.81%	-0.43%	-17.95%
Egypt	23.85M	18.63M	31.31M	76.25M	96.81M
Egypt Growth	28.01%	-40.49%	-58.94%	-21.23%	25.40%
Other Countries	756.18M	680.72M	810.71M	876.62M	733.55M
Other Countries Growth	11.08%	-16.03%	-7.52%	19.50%	-14.17%
Total	1.93B	1.76B	2.21B	1.85B	1.67B
Total Growth	10.15%	-20.58%	19.50%	10.87%	-23.21%

Source: S&P Global Market Intelligence.